Hearings, Meetings, Proceedings, etc.: Oncologic Drugs Advisory Committee, Supplemental Biologics License Application 761069/S-043 for Imfinzi (durvalumab) Injection

TitleHearings, Meetings, Proceedings, etc.: Oncologic Drugs Advisory Committee, Supplemental Biologics License Application 761069/S-043 for Imfinzi (durvalumab) Injection
ToC Doc Oncologic Drugs Advisory Committee, Supplemental Biologics License Application 761069/S-043 for Imfinzi (durvalumab) Injection
Docket Number2024-12532
Type Notice
Subject Hearings, Meetings, Proceedings, etc.:
Oncologic Drugs Advisory Committee, Supplemental Biologics License Application 761069/S-043 for Imfinzi (durvalumab) Injection
Publication Date2024-06-07
Last Updated Date 2024-06-06 08:21:29 -0400
Last Public Inspection2024-06-06
Filed At2024-06-06T08:45:00.000-04:00
PDF 2024-12532_PI.pdf (111732 bytes)
Download TXT / HTML / JSON
Number of Pages 6
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021